Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ACST- Sold for $5K loss. Surprised about this one, oh well, moving on.
jl- Best of luck, my friend. I'm still interested, again just waiting for the PPS to stabilize. -ob
Thanks for the thought, but the only results that I'm really interested in will be revealed in an hour or so when the market opens.
ACST- Announces successful PHII results- CaPre(R) Met All Primary and Key Secondary Endpoints.
https://finance.yahoo.com/news/acasti-reports-successful-capre-r-120000479.html
Let's see what happens now!
ACST- Announces successful PHII results- CaPre(R) Met All Primary and Key Secondary Endpoints.
https://finance.yahoo.com/news/acasti-reports-successful-capre-r-120000479.html
Let's see what happens now!
In spite of constant, moralistic, ridiculous harping on all iHub bio-boards about evil shorts, it's just another way to invest in the financial market. There's nothing inherently good or bad about it, any more than there is about driving a Ford, or living in Milwaukee, or the number 7. There is no conspiracy.
Additionally, there's a well-known theory that very often shorts actually know more about a stock than do longs. They do more research and have more specific, fact-based reasons for their trade rather than just jumping on a bandwagon. I agree.
No position here, still watching closely.
PS- IMHO Adam Feuerstein is one of the best biotech writers around, and NWBO is a bad joke worthy of his scorn.
ALIM says that the label is broader, details on Monday.
http://investor.alimerasciences.com/releasedetail.cfm?ReleaseID=873291
IMHO you're going to be fine if you keep your $$$ goal modest.
Because they did not reveal the all-important details about the label, and won't until Monday.
AMRN- Saw your post on another board, can't post there, responding here:
AMRN will go sub-$1 sooner or later. Unfortunately, many of the supporters/bagholders are angry and illogical conspiracy theorists (a common species on iHub bio boards) so there's no reasoning with them.
I've been playing it off and on for three years. I'm waiting to see two or three days of PPS increase on increased volume: sellers finally exhausted, buyers appearing. Then I'm going to jump in.
Best of luck.
calpre = CaPre
MNGA- No, the 8/20 Form 8-K says that the testing has been completed:
http://ir.stockpr.com/magnegas/sec-filings
The Naval Facilities Engineering Command website lists Project 480 (Alternative Metal Hot Cutting Operations For Opacity) status as Active:
http://www.nesdi.navy.mil/ProjectsCurrent.aspx
There were many fuels tested, going to take awhile to release the results. It's a complicated mixture of many factors: cost, speed, ease of use, shipboard dynamics, opacity, many more.
ECTE- LOL Tweet this morning. As far as announcing that they had to suspend operations in order to preserve liquidity, "I think I may stop breathing in order to conserve oxygen."
kei- Yep, I remember. The difference between this and DVAX, as of course you realize, is that with DVAX we were talking about a binary event involving an FDA ADCOM. Always a huge risk!
With ACST the event is simply the release of PH II trial results, which by all preliminary evidence should be fine. Still risky, but not as much.
We're both guessing, but perhaps I'd quibble a bit with your numbers. Don't think it would be cut in half, but it would take a big hit. Don't think it's going to double, but 50% is not out of the question.
Best of luck! -ob
Happy Hour is a one-hour block where everybody has the premium features enabled for them. You can do full-text searches, send private messages, etc.
Happy Hour is every Friday, from 4-5pm EST.
j.- No, not really necessary now: it was about holding losing positions in general, especially when they start to affect your daily life, not AMRN or the FDA or any of that stuff.
Feel free to PM me during Friday's 4-5 Happy Hour.
Best of luck in the future. -ob
I've looked at the TRIFECTA trial as closely as I'm able, and I think the results are going to be good.
I could sell now for a small profit, but I've decided to roll the dice with this one and hold-through.
Best of luck to all.
Still a decent gain.
I too am a bit disappointed in the lack of run-up, but after much research I've decided that the PH II TRIFECTA trial results are going to be good enough to cause a spike. Will sell then.
Best of luck in your other trades.
[Double OT]—At the risk of going too far afield, if one wanted to go way back with Intel, the relationship really started because of Arthur Rock—one of the company founders—who was a tremendous supporter of Israel and felt that he and other Jewish American businessmen could show their support by investing money there.
The NFL's overtime first possession touchdown rule is just ridiculous.
ACST- Still fully loaded+ on this one at $.98.
I feel confident the PH II TRIFECTA trial results will be excellent.
As usual I have a very modest personal goal of $1.17 and I think I can get that (an experienced and knowledgeable biotech person tells me he thinks my goal is too modest, but I'm not going to be greedy.)
Best of luck to all.
Ebola- From Virology Blog, the best thing I've read on why the virus is not going to go airborne:
http://www.virology.ws/2014/09/18/what-we-are-not-afraid-to-say-about-ebola-virus/
From Twitter:
BioRunUp ?@BioRunUp
$PSDV $3s again... somebody wants out before PDUFA
Of course they may want out through simple caution, or they may want out because there's a leak. That's biotech.
From Twitter: The FDA ‘Revolving Door’ Fosters Conflicts on Advisory Panels
http://blogs.wsj.com/pharmalot/2014/09/15/the-fda-revolving-door-fosters-conflicts-on-advisory-panels/
From the article: "I believe that the FDA is facing considerable difficulties finding qualified and experienced physicians who can offer an objective review of the data."
One more quick follow-up, as usual , just so I'm clear about it:
So the FDA does agree that triglyceride-reducing drugs also reduce cardiovascular risks, but only in the over 500 range?
AMRN - Dew or others: going to ask these two basic questions here rather than on the AMRN board, passions running a bit too high there. I'm still considering buying in, but waiting for the PPS to stabilize.
1. Perhaps over-simplifying, but am I correct in saying AMRN's main beef with the FDA is that while it agrees that Vascepa reduces triglycerides it will not accept this reduction as a validated surrogate for cardiovascular risk reduction?
2. Doesn't this refusal greatly affect all other companies working on triglyceride-reducing drugs? Specifically, I have a speculative position in ACST, they’re about to release PH II trial results for a krill-based product. If they’re ultimately going to run into the same roadblock, what’s the point?
TIA
I've done the same and still do but to a lesser degree. The days of automatic run-ups and automatic positive-result booms are over. The longer the hold the greater the missed-opportunity cost, and sometimes it turns out it just wasn't worth it.
Always hard to tell. Holding ACST here, best of luck with AEZS.
Would you agree that the African culture itself—still strongly infused with superstition—is playing no small part?
A belief that simply saying Ebola aloud makes the disease appear; that every death is triggered by enemies using witchcraft; that docs are deliberately killing patients and harvesting their organs; that Ebola is a punishment for sexual promiscuity, and more.
Of course, lest Westerners feel too superior, during Europe’s Black Death decades it was common knowledge that the plague was spread by the wind, caused by steam arising from the earth, a punishment from God for human sin, and the most popular: the Jews, aided by the devil, were poisoning the wells.
ARWR This is one on my watch list, but I'm a value buyer (read cheap) and it would have to drop all the way back to the mid-$12's for me to buy.
For your sake I hope it doesn't, and truthfully, I doubt it will. Best of luck.
It's really about abstract things like nationalism, patriotism, "our home", local rule, etc. Certainly about history.
But as far as practical economics, creating an independent nation will harm both Scotland and the UK.